Effects of berberine on differentiation and bone resorption of osteoclasts derived from rat bone marrow cells

Journal of Chinese Integrative Medicine

Volumn 7, Issue 4, 2009, Pages 342-348

  Wei, Peng ^a   Jiao, Lei ^a   Qin, Lu Ping ^a   Yan, Fei ^a   Han, Ting ^a   Zhang, Qiao Yan ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Berberine; Bone resorption; Osteoclasts; Osteoporosis

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; BERBERINE; CALCITRIOL; DEXAMETHASONE;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; COCULTURE; CONTROLLED STUDY; DRUG MECHANISM; IMAGE ANALYSIS; IMAGE PROCESSING; IN VITRO STUDY; MULTINUCLEAR CELL; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; RAT; STAINING;

ACID PHOSPHATASE; ANIMALS; BERBERINE; BONE MARROW CELLS; BONE RESORPTION; CELL DIFFERENTIATION; CELLS, CULTURED; ISOENZYMES; OSTEOCLASTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 68949219751     PISSN: 16721977     EISSN: None     Source Type: Journal    
DOI: 10.3736/jcim20090408     Document Type: Article

References (24)

1. Dai RC, Zhang L, Liao EY. Progress in diagnosis and treatment of osteoporosis. Zhongguo Yi Kan. 2008; 43 (4): 4-6.
2. Davison S, Davis SR. Hormone replacement therapy: current controversies. Clin Endocrinol (Oxf). 2003; 58 (3): 249-261.
3. Hu JP, Takahashi N, Yamada T. Coptidis rhizoma inhibits growth and proteases of oral bacteria. Oral Dis. 2000; 6(5): 297-302.
4. Anis KV, Rajeshkumar NV, Kuttan R. Inhibition of chemical carcinogenesis by berberine in rats and mice. J Pharm Pharmacol. 2001; 53(5): 763-768.
5. Hwang JM, Kuo HC, Tseng TH, Liu JY, Chu CY. Berberine induces apoptosis through a mitochondria/caspases pathway in human hepatoma cells. Arch Toxicol. 2006; 80(2): 62-73.
6. Kuo CL, Chou CC, Yung BY. Berberine complexes with DNA in the berberine-induced apoptosis in human leukemic HL-60 cells. Cancer Lett. 1995; 93(2): 193-200.
7. 1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells. Mol Cancer Ther. 2006; 5(2): 296-308.
8. Li H, Miyahara T, Tezuka Y, Namba T, Nemoto N, Tonami S, Seto H, Tada T, Kadota S. The effect of Kampo formulae on bone resorption in vitro and in vivo. I. Active constituents of Tsu-kan-gan. Biol Pharm Bull. 1998; 21(12): 1322-1326.
9. Li H, Miyahara T, Tezuka Y, Namba T, Suzuki T, Dowaki R, Watanabe M, Nemoto N, Tonami S, Seto H, Kadota S. The effect of kampo formulae on bone resorption in vitro and in vivo. II. Detailed study of berberine. Biol Pharm Bull. 1999; 22(4): 391-396.
10. Qin L, Han T, Zhang Q, Cao D, Nian H, Rahman K, Zheng H. Antiosteoporotic chemical constituents from Er-Xian Decoction, a traditional Chinese herbal formula. J Ethnopharmacol. 2008; 118(2): 271-279.
11. Nian H, Xu LL, Ma MH, Zheng HC, Zhang QY, Qin LP. Effects of berberine from Cortex Phellodendri Chinensis on osteoporosis in ovariectomized rats. Yao Xue Fu Wu Yu Yan Jiu. 2007; 7(1): 41-44.
12. Hu JP, Nishishita K, Sakai E, Yoshida H, Kato Y, Tsukuba T, Okamoto K. Berberine inhibits RANKL-induced osteoclast formation and survival through suppressing the NF-kappaB and Akt pathways. Eur J Pharmacol. 2008; 580(1-2): 70-79.
13. Rodan GA, Martin TJ. Role of osteoblasts in hormonal control of bone resorption - a hypothesis. Calcif Tissue Int. 1981; 33(4): 349-351.
14. Rodan GA, Martin TJ. Therapeutic approaches to bone diseases. Science. 2000; 289(5484): 1508-1514.
15. Teitelbaum SL. Bone resorption by osteoclasts. Science. 2000; 289(5484): 1504-1508.
16. Zhang QH, Gao HY, Wu LJ, Zhang L. Chemical constituents of Evodia rutaecarpa (Juss.) Benth.. Shenyang Yao Ke Da Xue Xue Bao. 2005; 22(1): 12-14.
17. Liu ZD, Zang HS, Ouyang YP. Biological study of growth pattern of newborn rat calvaria osteoblastic cell in vitro. Jie Pou Xue Bao. 1995; 26(2): 157-160.
18. Li B, Yu S. Genistein prevents bone resorption diseases by inhibiting bone resorption and stimulating bone formation. Biol Pharm Bull. 2003; 26(6): 780-786.
19. Yasukawa K, Takido M, Ikekawa T, Shimada F, Takeuchi M, Nakagawa S. Relative inhibitory activity of berberine-type alkaloids against 12-O-tetrade-canoylphorbol-13-acetate-induced inflammation in mice. Chem Pharm Bull (Tokyo). 1991; 39(6): 1462-1465.
20. Fukuda K, Hibiya Y, Mutoh M, Koshiji M, Akao S, Fujiwara H. Inhibition by berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cells. J Ethnopharmacol. 1999; 66(2): 227-233.
21. 2 signaling systems results in enhancement of osteoclastogenesis through effects on the osteoprotegerin/receptor activator of nuclear factor-kappaB (RANK) ligand/RANK system. Endocrinology. 2005; 146(4): 1991-1998.
22. Zhang X, Schwarz EM, Young DA, Puzas JE, Rosier RN, O'Keefe RJ. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J Clin Invest. 2002; 109(11): 1405-1415.
23. Ono K, Akatsu T, Murakami T, Kitamura R, Yamamoto M, Shinomiya N, Rokutanda M, Sasaki T, Amizuka N, Ozawa H, Nagata N, Kugai N. Involvement of cyclo-oxygenase-2 in osteoclast formation and bone destruction in bone metastasis of mammary carcinoma cell lines. J Bone Miner Res. 2002; 17(5): 774-781.
24. Zhang X, Morham SG, Langenbach R, Young DA, Xing L, Boyce BF, Puzas EJ, Rosier RN, O'Keefe RJ, Schwarz EM. Evidence for a direct role of cyclo-oxygenase 2 in implant wear debris-induced osteolysis. J Bone Miner Res. 2001; 16(4): 660-670.